Retinal light response deficits persist after vascular recovery in ROP models
Retinopathy of prematurity has long been framed as a disorder of abnormal blood vessel growth. In practice, the disease appears to leave a deeper footprint. Even when retinal vascular development recovers, many patients continue to show impaired light responses for years, sometimes for life, which means the clinical problem extends beyond neovascular injury alone.
The central message of this review is straightforward: retinal light response deficits in retinopathy of prematurity likely arise from neuronal injury, not just vascular disruption. Mouse and rat oxygen-induced retinopathy models have been indispensable for understanding the angiogenic side of the disease and for supporting anti-VEGF therapy development. Their value now extends into a different domain, because they also offer a way to study how retinal circuitry fails to recover normal visual signaling after the vessels remodel.
Photoreceptor dysfunction appears to start the cascade
Evidence across OIR studies points first to the photoreceptors. These cells convert light into electrical signals, so any early injury at that level can reverberate through the rest of the retina. When photoreceptors are stressed during abnormal oxygen exposure and subsequent hypoxic injury, the resulting defect is not limited to a single cell layer; it changes the quality of the signal entering the entire retinal network.
A one-sentence clinical reality follows from that biology: restoring vessels does not automatically restore vision.
The review argues that photoreceptor impairment likely initiates a chain reaction. Once the first step in visual transduction weakens, downstream neurons receive a distorted input and must process a signal that is already biologically degraded. In that setting, functional testing may continue to show abnormalities even after the vascular architecture looks improved on examination or imaging. This helps explain why a child can survive the vascular phase of ROP without having normal visual performance later on.
Retinal circuitry amplifies early injury
The downstream consequences matter because the retina functions as a layered circuit rather than a collection of isolated cells. Signals pass from photoreceptors to bipolar cells, then through amacrine and ganglion cell networks before leaving the eye. If the initial drive from photoreceptors is weak, every later relay inherits that defect. The review describes cumulative impairment across retinal cell populations, with deficits propagating through the circuit instead of remaining confined to one compartment.
This matters for interpretation of experimental work. Studies that focus only on neovascular endpoints can miss functional injury that persists after revascularization. OIR models, by contrast, make it possible to assess both vascular remodeling and retinal physiology in the same disease framework. That dual view is especially useful for a condition like ROP, where the eye may appear structurally improved while neuroretinal signaling remains compromised.
The mechanism is biologically plausible. Oxygen stress during critical developmental windows can alter maturation, synaptic signaling, and cellular resilience. Once those developmental processes are disrupted, the retina may not simply “catch up” after blood vessels stabilize. Instead, the circuit can retain a developmental scar in the form of muted light responsiveness.
Why the OIR platform still matters
The review places substantial value on the oxygen-induced retinopathy model because it mirrors key features of premature retinal injury while remaining experimentally tractable. OIR has already proven useful in the anti-VEGF era, where it helped define the vascular biology of pathologic neovascularization. Its broader contribution now is mechanistic: it gives investigators a way to study how retinal neurons respond to the same developmental insult that injures the vasculature.
That broader use is clinically important. Premature infants with ROP do not present with vascular pathology alone; the long-term burden is often visual. If retinal light response deficits originate in photoreceptors and spread across the retinal network, then future therapies may need to preserve or restore neuronal function in addition to suppressing vessel growth. In other words, a treatment strategy that succeeds angiographically but ignores retinal signaling may leave a major component of disease untreated.
Therapeutic implications reach beyond anti-VEGF therapy
Anti-VEGF treatment changed the management of severe retinal neovascular disease, but it was never designed to repair the entire visual pathway. The review makes clear that the next frontier is not only preventing abnormal vessels. It is also understanding how to protect the neuronal component of ROP, especially during the developmental period when the retina is still wiring itself.
The bedside implication is direct. Long-term follow-up of infants treated for ROP should not stop at vascular stability. Functional outcomes matter, and persistent light response deficits may reflect underlying neuronal injury even when retinal vessels no longer appear active. That gap between anatomy and function is where future therapeutic development will likely need to focus.
Because the retina develops as an integrated sensory network, a therapy aimed at one compartment may be insufficient if other compartments have already been injured. Photoreceptor dysfunction can set the stage, but the full loss of sensitivity may emerge only after the signal moves through the rest of the circuit. OIR models are uniquely suited to dissect that sequence because they can be used to track the injury from the outer retina inward.
Remaining knowledge gaps define the next phase of study
The review is careful in what it claims and equally careful in what it leaves unresolved. The exact mechanisms behind persistent light response deficits in ROP remain poorly understood. The relative contribution of photoreceptor injury, synaptic disruption, bipolar cell dysfunction, and broader network remodeling still needs sharper definition. Without that map, it is difficult to design therapies that target the right cellular step at the right developmental time.
The challenge is not merely academic. Children born prematurely can carry visual deficits long after the acute vascular phase has passed, and those deficits may reflect retinal injury that current standard treatments do not address. A better mechanistic understanding of OIR could therefore influence how investigators design neuroprotective strategies, how clinicians think about follow-up, and how future trials define success.
For now, the evidence supports a more expansive view of ROP. It is a vascular disease, but not only a vascular disease. The persistent failure of light responses after vascular recovery suggests a layered injury process, one that begins in photoreceptors and spreads through the retinal circuit. Any therapy meant to improve long-term vision will need to confront both sides of that equation.